Tizanidine Tablets/Capsules Suppliers & Bulk Manufacturers
Available Forms: Oral Capsules/Tablets
Available Strengths: 2 mg and 4 mg
Reference Brands: Zanaflex (US)
Category: Multiple sclerosis
Tizanidine tablets/capsules is available in Oral Capsules/Tablets and strengths such as 2 mg and 4 mg. Sourced from GMP-certified and ISO-compliant manufacturers, this API meets global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical formulation and commercial manufacturing, Tizanidine tablets/capsules is supplied in bulk quantities with complete regulatory support including DMF, COA, and MSDS.
| Technical Specifications & Supply Details | |
|---|---|
| Lead Time | 7 to 60 days (depending on batch size & schedule) |
| MOQ | As per manufacturer’s batch size |
| COA | Available with every batch |
| Regulatory Dossier / DMF | Available upon request |
| Export Documentation | FSC, COA, Manufacturing License, Product Permission |
| Standards | IP, BP, USP |
| Certifications | WHO-GMP, EU-GMP, USFDA (as applicable) |
Tizanidine tablets/capsules can be exported to over 30 countries across Asia, Africa, Europe, and Latin America. Flexible packaging, competitive pricing, and a verified supplier network make Pharmatradz a trusted sourcing partner for pharmaceutical companies and contract manufacturers worldwide.
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Product Description:
Tizanidine tablets, marketed as Zanaflex, are approved in the US by the FDA and in the EU via EMA for relief of spasticity associated with neurological conditions. Regulatory approval requires a detailed dossier including clinical efficacy, safety data, manufacturing standards, and pharmacovigilance plans. In the US, the FDA reviews comprehensive clinical trial and manufacturing data, while the EMA ensures regional safety and quality compliance. For guidance on dossier preparation, regulatory pathways, and market access, visit PharmaTradz. Ensuring compliance is essential for timely approval, safe use, and global availability of tizanidine tablets, supporting effective management of spasticity worldwide.
Frequently Asked Questions
Related Products
Lamotriginevdispersible Tablets
Strength:
XR: 25 mg, 50 mg, 100 mg, 200 mg; IR: 25 mg, 100 mg, 200 mg, 300 mg
Form: Tablets(IR & ER)
Reference Brands: Lamictal, Lamictal XR(EU & US)
View Details
Tolterodine Tablets/ Capsules(Ir & Er)
Strength:
IR: 1 mg, 2 mg; ER: 2mg, 4 mg
Form: Tablets/ Capsules(IR & ER)
Reference Brands: Detrol, Detrol LA(US & EU)
View Details
Oxybutynin Tstransdermal Patch
Strength:
3.9 mg/24 hours
Form: transdermal patch
Reference Brands: Oxytrol, Oxytrol for Women(US & EU)
View Details
Oxybutynin Tablets
Strength:
IR: 5 mg, 10 mg; ER: 5 mg, 10 mg
Form: Tablet(IR & ER)
Reference Brands: Ditropan, Oxybutynin XL(US)
View DetailsQuick Response Guaranteed | Verified Suppliers
